Xing Zhao

1.2k total citations
55 papers, 859 citations indexed

About

Xing Zhao is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xing Zhao has authored 55 papers receiving a total of 859 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Xing Zhao's work include Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (9 papers) and MicroRNA in disease regulation (8 papers). Xing Zhao is often cited by papers focused on Cancer-related molecular mechanisms research (16 papers), Circular RNAs in diseases (9 papers) and MicroRNA in disease regulation (8 papers). Xing Zhao collaborates with scholars based in China, United States and Netherlands. Xing Zhao's co-authors include Jianzhen Xu, Yujie Cai, Hongyan Dong, Jun Feng, Changchun Shao, Fan Zhang, Guo‐Jun Zhang, Qian Ying, Min Chen and Chunfa Chen and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and PLoS ONE.

In The Last Decade

Xing Zhao

51 papers receiving 849 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Zhao China 14 671 523 58 56 45 55 859
Si Yu China 15 465 0.7× 258 0.5× 49 0.8× 40 0.7× 62 1.4× 31 707
Marc Hirschfeld Germany 19 656 1.0× 435 0.8× 61 1.1× 24 0.4× 41 0.9× 45 905
Zeping Han China 17 804 1.2× 520 1.0× 55 0.9× 160 2.9× 62 1.4× 47 1.0k
Di Peng China 10 522 0.8× 281 0.5× 28 0.5× 29 0.5× 54 1.2× 25 691
Chenyang Yu China 14 417 0.6× 324 0.6× 30 0.5× 35 0.6× 96 2.1× 27 639
Ryou‐u Takahashi Japan 14 506 0.8× 323 0.6× 64 1.1× 36 0.6× 52 1.2× 31 727
Chao Shen China 14 779 1.2× 550 1.1× 134 2.3× 25 0.4× 50 1.1× 33 1.0k

Countries citing papers authored by Xing Zhao

Since Specialization
Citations

This map shows the geographic impact of Xing Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Zhao more than expected).

Fields of papers citing papers by Xing Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Zhao. The network helps show where Xing Zhao may publish in the future.

Co-authorship network of co-authors of Xing Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Zhao. A scholar is included among the top collaborators of Xing Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Zhao. Xing Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Bing, Hong Liu, Jiaxin Xu, et al.. (2025). Structural and functional alteration of the gut microbiomes in ICU staff: a cross-sectional analysis. Critical Care. 29(1). 141–141. 1 indexed citations
2.
Mou, Chunxiao, Xing Zhao, Zhuo Chen, et al.. (2025). The mRNA vaccine expressing fused structural protein of PRRSV protects piglets against PRRSV challenge. Veterinary Microbiology. 305. 110534–110534. 4 indexed citations
3.
Yang, Yanhui, Xing Zhao, Hao Wang, et al.. (2025). PSMD11 and PSMD14 may serve as novel biomarkers for the prognosis of pancreatic ductal adenocarcinoma. Frontiers in Oncology. 15. 1555649–1555649. 1 indexed citations
4.
Liu, Yaqi, et al.. (2024). The role of exercise-related FNDC5/irisin in depression. Frontiers in Pharmacology. 15. 1461995–1461995. 4 indexed citations
5.
Liu, Yichen, Xing Zhao, Reyhaneh Ravanbakhsh Gavgani, et al.. (2024). Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity. Scientific Reports. 14(1). 8730–8730. 2 indexed citations
6.
Wang, Conghui, et al.. (2024). Self-Assembled Nanocomposite DOX/TPOR4@CB[7]4 for Enhanced Synergistic Photodynamic Therapy and Chemotherapy in Neuroblastoma. Pharmaceutics. 16(6). 822–822. 1 indexed citations
7.
Chen, Qiuyang, et al.. (2023). Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m6A methylation. Cancer Science. 114(8). 3216–3229. 8 indexed citations
8.
9.
Liu, Ying, et al.. (2022). Characterisation of circulating endothelial microparticles in Behçet's disease: new markers of chronic endothelial damage?. Clinical and Experimental Rheumatology. 41(10). 1970–1975.
10.
Zhao, Xing, Shengfa Su, Jun Zhang, et al.. (2022). Recombinant human endostatin combined with radiotherapy promotes cardiomyocyte apoptosis in rats via TGFβ1/Smads/CTGF signaling pathway. BMC Cardiovascular Disorders. 22(1). 97–97. 4 indexed citations
11.
Liu, Shasha, et al.. (2021). miR-301-3p directly regulates Cx43 to mediate the development of gastric cancer. Journal of International Medical Research. 49(9). 3619094113–3619094113. 4 indexed citations
12.
Zhao, Xing, et al.. (2021). TRA2A Binds With LncRNA MALAT1 To Promote Esophageal Cancer Progression By Regulating EZH2/β-catenin Pathway. Journal of Cancer. 12(16). 4883–4890. 19 indexed citations
13.
Zhang, Feng, Xing Zhao, Liu P, et al.. (2019). LncRNA GAS5-mediated miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Ma, Xiao, Fan Su, Zijie Wang, et al.. (2019). A single center study of protective and susceptible HLA alleles and haplotypes with end-stage renal disease in China. Human Immunology. 80(11). 943–947. 12 indexed citations
15.
Xu, Jianzhen, Changchun Shao, Xiaojia Wang, et al.. (2019). circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death and Disease. 10(3). 175–175. 205 indexed citations
16.
Cheng, Yinwei, Yunmei Chen, Qianqian Zhao, et al.. (2019). Long Read Single-Molecule Real-Time Sequencing Elucidates Transcriptome-Wide Heterogeneity and Complexity in Esophageal Squamous Cells. Frontiers in Genetics. 10. 915–915. 12 indexed citations
17.
Li, Hongping, Xing Zhao, Qi‐Wei Zhang, et al.. (2014). Solid-phase methylamidation for sialoglycomics by MALDI-MS. Analytical and Bioanalytical Chemistry. 406(25). 6235–6246. 11 indexed citations
18.
Li, Rongshan, et al.. (2013). [Effects of leflunomide on high glucose-induced podocyte cytoskeleton and its mechanism].. PubMed. 93(10). 780–4. 1 indexed citations
19.
Freifeld, Alison G., Kari Simonsen, Christine S. Booth, et al.. (2012). A New Rapid Method for Clostridium difficile DNA Extraction and Detection in Stool. Journal of Molecular Diagnostics. 14(3). 274–279. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Si Yu Breakdown of academic impact, for papers by Marc Hirschfeld Breakdown of academic impact, for papers by Zeping Han Breakdown of academic impact, for papers by Di Peng Breakdown of academic impact, for papers by Chenyang Yu Breakdown of academic impact, for papers by Ryou‐u Takahashi Breakdown of academic impact, for papers by Chao Shen
Rankless by CCL
2026